Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:17 AM
NCT ID: NCT01927120
Description: None
Frequency Threshold: 0
Time Frame: 2 years, 6 months
Study: NCT01927120
Study Brief: In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
GVHD Regimen Graft versus host disease (GVHD) prophylaxis regimen IL-2 with Sirolimus and Tacrolimus after allogeneic hematopoietic cell transplant (HCT). None None 11 20 4 20 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Sinus tachycardia NON_SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (4.0) View
Colonic hemorrhage NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Vomiting NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Fever NON_SYSTEMATIC_ASSESSMENT General disorders CTCAE (4.0) View
Pain NON_SYSTEMATIC_ASSESSMENT General disorders CTCAE (4.0) View
Hepatobiliary disorders - Other, VOD NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders CTCAE (4.0) View
Generalized muscle weakness NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (4.0) View
Acute kidney injury NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (4.0) View
Cystitis non-infective NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (4.0) View
Renal and urinary disorders - Other, adenovirus cystitis NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (4.0) View
Renal and urinary disorders - Other, kidney stones NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (4.0) View
Portal vein thrombosis NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders CTCAE (4.0) View
Infections and infestations - Other, pneumonia NON_SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (4.0) View
Infections and infestations - Other, staphylococcus epidermis bacteremia NON_SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (4.0) View
Sepsis NON_SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (4.0) View
Intracranial hemorrhage NON_SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (4.0) View
Hypotension NON_SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (4.0) View
Anemia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (4.0) View
Atrial fibrillation NON_SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (4.0) View
Abdominal pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Alanine aminotransferase increased NON_SYSTEMATIC_ASSESSMENT Investigations CTCAE (4.0) View
Ileus NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View
Hepatobiliary disorders - Other, portal vein thrombosis NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders CTCAE (4.0) View
Aspartate aminotransferase increased NON_SYSTEMATIC_ASSESSMENT Investigations CTCAE (4.0) View
Hypertension NON_SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (4.0) View